UK Markets closed

Enanta Pharmaceuticals, Inc. (9EP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
51.00+1.00 (+2.00%)
At close: 07:55PM CET
Currency in EUR
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts8478
Avg. Estimate-1.34-1.17-4.05-5.49
Low estimate-1.87-1.39-4.56-7.02
High estimate-0.67-0.74-3.37-3.93
Year ago EPS-1.46-0.41-1.81-4.05
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts8378
Avg. Estimate25.05M25.69M99.14M100.02M
Low estimate16.5M15.72M90M62.86M
High estimate32.16M31.1M105.66M128.65M
Year ago sales23.63MN/A122.47M99.14M
Sales growth (year/est)6.00%N/A-19.10%0.90%
Earnings history30/09/202031/12/202031/03/202130/06/2021
Est. EPS-0.95-0.74-0.98-1.28
Actual EPS-1.46-0.41-1.09-1.19
Difference-0.510.33-0.110.09
Surprise %-53.70%44.60%-11.20%7.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-1.34-1.17-4.05-5.49
7 days ago-1.34-1.17-4.05-5.49
30 days ago-1.31-1.17-4.03-5.58
60 days ago-1.12-1.02-3.98-5.11
90 days ago-1.08-1.02-3.91-4.99
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates9EP.FIndustrySector(s)S&P 500
Current qtr.8.20%N/AN/AN/A
Next qtr.-185.40%N/AN/AN/A
Current year-123.80%N/AN/AN/A
Next year-35.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)-10.60%N/AN/AN/A